PI
MRNA icon

Putnam Investments’s Moderna MRNA Stock Holding History

Putnam Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,369
Closed -$210K – 1190
2023
Q1 		$210K Sell
1,369
-47
-3% -$7.75K ﹤0.01% 1118
2022
Q4 		$254K Buy
+1,416
New +$232K ﹤0.01% 1093
2022
Q3 		– Sell
-26,884
Closed -$3.84M – 1186
2022
Q2 		$3.84M Sell
26,884
-61,549
-70% -$8.8M 0.01% 516
2022
Q1 		$15.2M Sell
88,433
-71,562
-45% -$12M 0.02% 269
2021
Q4 		$40.6M Sell
159,995
-86,458
-35% -$25.3M 0.06% 175
2021
Q3 		$94.8M Buy
+246,453
New +$90.9M 0.15% 135
2021
Q1 		– Sell
-46,301
Closed -$4.84M – 814
2020
Q4 		$4.84M Buy
+46,301
New +$4.68M 0.01% 501

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Putnam Investments's MRNA Position: Q2 2023 in Review

Putnam Investments sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,369 shares — an estimated $210K sold.

Putnam Investments first reported a position in MRNA in Q4 2020 and held it in 7 quarters. The position peaked at $94.8M in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Putnam Investments reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Putnam Investments sold 1,369 Moderna shares in Q2 2023, an estimated $210K.
  • Putnam Investments first reported a position in Moderna in Q4 2020 and held it in 7 quarters.
  • Putnam Investments's Moderna position peaked at $94.8M in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Putnam Investments's 13F filing for Q2 2023, filed 14 Aug 2023.